InMed Pharmaceuticals Inc. Stock Analysis & AI Score
InMed Pharmaceuticals Inc. (INM) has an ST Score of 47.6 (C+), driven by its Growth (A-) and held back by its Profitability (C-). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
InMed Pharmaceuticals Inc. (INM) has an ST Score of 47.6 (C+), driven by its Growth (A-) and held back by its Profitability (C-). Analysts rate it Buy.
- Strongest
- GrowthA-
- Weakest
- ProfitabilityC-
All factor grades
- GrowthA-
- Financial StrengthB
- ValuationB-
- MomentumC
- ProfitabilityC-
- Piotroski2/9
Contact
INM stock: frequently asked questions
What is INM's ST Score?
InMed Pharmaceuticals Inc. (INM) has an ST Score of 47.6 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is INM a buy, hold, or sell?
Analysts rate INM a Buy. Our ST Score grades it C+ (47.6/100). The ST Score is a data-driven signal, not a recommendation.
What are INM's factor grades?
Valuation B-, Profitability C-, Financial Strength B, Momentum C, Growth A-.
What is INM's valuation grade?
InMed Pharmaceuticals Inc. (INM) earns a valuation grade of B-, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is INM's growth grade?
InMed Pharmaceuticals Inc. (INM) earns a growth grade of A-, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is INM's profitability grade?
InMed Pharmaceuticals Inc. (INM) earns a profitability grade of C-, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is INM's financial strength grade?
InMed Pharmaceuticals Inc. (INM) earns a financial strength grade of B, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is INM's Piotroski score?
InMed Pharmaceuticals Inc. (INM) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.